找回密碼
 To register

QQ登錄

只需一步，快速開(kāi)始

掃一掃，訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers in Cancer; Victor R. Preedy,Vinood B. Patel Reference work 2015 Springer Science+Business Media Dordrecht 2015 Application to p

[復(fù)制鏈接]
查看: 18149|回復(fù): 57
樓主
發(fā)表于 2025-3-21 19:38:36 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱(chēng)Biomarkers in Cancer
影響因子2023Victor R. Preedy,Vinood B. Patel
視頻videohttp://file.papertrans.cn/188/187805/187805.mp4
發(fā)行地址Transcends the intellectual-divide with Key Facts (areas of focus explained for the lay person), Definitions Of Words And Terms, and Summary Points..Wide applicability with each chapter containing a s
圖書(shū)封面Titlebook: Biomarkers in Cancer; Victor R. Preedy,Vinood B. Patel Reference work 2015 Springer Science+Business Media Dordrecht 2015 Application to p
影響因子The World Health Organisation have reported that each year on a global basis there are over 8 million deaths from cancer. This is 13% of all deaths. As well as those who die, there are many who are being treated for cancer. Some cancers, hitherto deemed to be incurable, can now be cured. Part of the overall package of healthcare related to cancer is the application of biomarkers.? Biomarkers can be used not only to determine stages and effects of cancer, but also to aid treatments regimes. .Biomarkers in Cancer. combines detailed information on cancer types and the use of biological indicators. It covers the latest knowledge, trends and applications.? It links conventional approaches with new platforms
Pindex Reference work 2015
The information of publication is updating

書(shū)目名稱(chēng)Biomarkers in Cancer影響因子(影響力)




書(shū)目名稱(chēng)Biomarkers in Cancer影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Biomarkers in Cancer網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Biomarkers in Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Biomarkers in Cancer被引頻次




書(shū)目名稱(chēng)Biomarkers in Cancer被引頻次學(xué)科排名




書(shū)目名稱(chēng)Biomarkers in Cancer年度引用




書(shū)目名稱(chēng)Biomarkers in Cancer年度引用學(xué)科排名




書(shū)目名稱(chēng)Biomarkers in Cancer讀者反饋




書(shū)目名稱(chēng)Biomarkers in Cancer讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:13:32 | 只看該作者
Forschungsstand zur Europ?isierungmerging blood-based molecular biomarkers that have been evaluated for the detection and monitoring of lung cancer. We specially focus on biomarkers based on a non-invasive liquid biopsy approach, such as circulating tumor cells (CTCs), circulating miRNAs, gene promoter methylation, and DNA mutations in cell-free circulating DNA.
板凳
發(fā)表于 2025-3-22 03:22:33 | 只看該作者
Epigenetics and Biomarkers in Lung Cancer: Emerging Blood-Based Molecular Biomarkers for Detection amerging blood-based molecular biomarkers that have been evaluated for the detection and monitoring of lung cancer. We specially focus on biomarkers based on a non-invasive liquid biopsy approach, such as circulating tumor cells (CTCs), circulating miRNAs, gene promoter methylation, and DNA mutations in cell-free circulating DNA.
地板
發(fā)表于 2025-3-22 08:35:12 | 只看該作者
5#
發(fā)表于 2025-3-22 12:19:25 | 只看該作者
6#
發(fā)表于 2025-3-22 13:12:02 | 只看該作者
7#
發(fā)表于 2025-3-22 17:27:22 | 只看該作者
DNA Methylation as a Biomarker in Cancer in comparison with others, and their status in applications of DNA methylation biomarkers in cancer. The research field of DNA methylation biomarking is evolving rapidly with promising results that have the potential to confer enormous benefits for cancer patients in the future.
8#
發(fā)表于 2025-3-22 22:30:14 | 只看該作者
9#
發(fā)表于 2025-3-23 04:31:05 | 只看該作者
Konfliktmanagement im Unternehmennce of KLKs. KLK members have been proposed as tissue and/or serological biomarkers for early diagnosis, effective prognosis, and treatment monitoring of cancer patients. This chapter presents an overview of the current knowledge concerning the immense potential of KLKs as biomarkers in human malignancies.
10#
發(fā)表于 2025-3-23 08:07:42 | 只看該作者
Forschungsstand zur Europ?isierungassociated with higher metastasis risk and poor outcome. Complete and standardized methods to study maspin are necessary in order to evaluate its therapeutic implications and to understand how different subcellular distributions and epigenetic alterations could be helpful for a shared interpretation of results.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 04:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
铁力市| 北票市| 宁都县| 柳林县| 安福县| 大同市| 固阳县| 汉沽区| 白河县| 滦平县| 长春市| 康平县| 商都县| 兴城市| 宜州市| 惠州市| 阜宁县| 迁西县| 赞皇县| 兖州市| 芜湖县| 乌拉特中旗| 张家界市| 邳州市| 阳曲县| 聂荣县| 万州区| 昔阳县| 麻江县| 奈曼旗| 辽源市| 志丹县| 姜堰市| 晴隆县| 刚察县| 民县| 大方县| 兴安盟| 交口县| 北京市| 崇礼县|